ArticleBMC cancer2024

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.

Wei-Xiang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.